A trial of fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis (RRMS)
Latest Information Update: 19 Feb 2016
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 19 Feb 2016 New trial record